Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12)

Copy Product Info
😃Good
Catalog No. T9901A-1992

Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) is a rat-derived inhibitory antibody that targets mouse PD-1 and blocks its binding to both PD-L1 and PD-L2 ligands.It is suitable for cancer and immunology research, including CT26 tumors and pancreatic cancer models .

Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12)

Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12)

Copy Product Info
😃Good
Purity: 95%
Catalog No. T9901A-1992
Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) is a rat-derived inhibitory antibody that targets mouse PD-1 and blocks its binding to both PD-L1 and PD-L2 ligands.It is suitable for cancer and immunology research, including CT26 tumors and pancreatic cancer models .
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$6854-6 weeks4-6 weeks
5 mg$1,5004-6 weeks4-6 weeks
10 mgPreferential4-6 weeks4-6 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:95%
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) is a rat-derived inhibitory antibody that targets mouse PD-1 and blocks its binding to both PD-L1 and PD-L2 ligands.It is suitable for cancer and immunology research, including CT26 tumors and pancreatic cancer models .
In vitro
Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) (10 μg/mL, 7 days), when combined with anti-CTLA-4,increases the production of IFN-γ cytokine and the expression of Ki-67 in CD8+CTLA-4+PD-1+ tumor-infiltrating lymphocytes from CT26 tumors [1].
In vivo
Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) (200 μg, intraperitoneal injection on days 10, 13 and 16) combined with anti-CTLA-4 induces tumor regression in CT26/ID8-VEGF tumor-bearing mice [1].
Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) (100 μg, intraperitoneal injection on days 1, 3 and 5 after BRAF inhibitor administration) combined with a BRAF inhibitor inhibits tumor growth and prolongs survival in BP tumor-bearing mice [2].
Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) (200 μg, intraperitoneal injection on days 4, 7 and 10) combined with a PRIP1 inhibitor protects mice against primary pancreatic cancer and liver metastasis [3].
Clone
29F.1A12
Reactivity
Mouse
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetPD-1/CD279
Chemical Properties
Molecular Weight150 kDa
Antibody Information
IsotypeMouse IgG1 kappa
Recommended Isotype Control
Storage & Solubility Information
Storagestore at low temperature | -20°C for 2 years, 4°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) | purchase Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) | Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) cost | order Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) | Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) in vivo | Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) in vitro | Anti-Mouse PD-1/CD279 (D265A) Antibody (29F.1A12) molecular weight